A Randomised Phase III study of Temozolomide and short-course radiation versus short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients.
Primary Sponsor
NCIC Clinical Trials Group (NCIC CTG)
Related Post
12 August, 2025
TROG 15.03/ANZUP 16001 FASTRACK II: economic analysis shows new technique is cheaper and more effective in the Australian setting
TRIAL UPDATE: 12 August 2025 Treating inoperable kidney cancer
31 July, 2025
World Lung Cancer Day: Focus on the TROG Lung Working Party
TROG WORKING PARTY IN FOCUS: 31 July 2025 To